Surfing the MASH Tsunami

Send us Fan Mail For the first time, Surfing NASH takes a deep dive into the prospect of digital therapeutics, their ability to drive outcomes and the critical success factors for proper use and deployment. This is an increasingly apt topic which intermittently surfaces on the podcast but has never featured at the center of conversation. The Surfers are joined by Naim Alkhouri and two new guests w...

Send us Fan Mail For the first time, Surfing NASH takes a deep dive into the prospect of digital therapeutics, their ability to drive outcomes and the critical success factors for proper use and deployment. This is an increasingly apt topic which intermittently surfaces on the podcast but has never featured at the center of conversation. The Surfers are joined by Naim Alkhouri and two new guests w...

Send us Fan Mail For the first time, Surfing NASH takes a deep dive into the prospect of digital therapeutics, their ability to drive outcomes and the critical success factors for proper use and deployment. This is an increasingly apt topic which intermittently surfaces on the podcast but has never featured at the center of conversation. The Surfers are joined by Naim Alkhouri and two new guests w...

Send us Fan Mail For the first time, Surfing NASH takes a deep dive into the prospect of digital therapeutics, their ability to drive outcomes and the critical success factors for proper use and deployment. This is an increasingly apt topic which intermittently surfaces on the podcast but has never featured at the center of conversation. The Surfers are joined by Naim Alkhouri and two new guests w...

Send us Fan Mail This week's episode From the Vault comes from Season 2, Episode 59.3. Lead author Jeffrey Lazarus and co-author Jörn Schattenberg join Stephen Harrison, Louise Campbell, and Roger Green to discuss the groundbreaking paper “ Advancing the Global Health Agenda for NAFLD .” This conversation focuses on what will happen now, why NAFLD is “the canary in the coal mine,” and how we...

Send us Fan Mail In the final conversation on AASLD’s new practice guidance , Roger Green contextualizes a new project he is embarking on with Ken Cusi. Together as co-hosts, they will be debuting a new podcast series from next week titled The NASH Tsunami in Diabetes: Getting Ahead of the Rising Tide . The content featured will largely be targeted toward healthcare professionals who treat diabeti...

Send us Fan Mail Late last week, AASLD published new practice guidance on the clinical assessment and management of NAFLD. The Surfers convene with Ken Cusi, who contributed to the previous iteration published in 2018, to explore its key features and implications. The updated document reflects the many advances pertinent to any practitioner caring for patients with NAFLD. This conversation focuses...

Send us Fan Mail Late last week, AASLD published new practice guidance on the clinical assessment and management of NAFLD. The Surfers convene with Ken Cusi, who contributed to the previous iteration published in 2018, to explore its key features and implications. The updated document reflects the many advances pertinent to any practitioner caring for patients with NAFLD. This conversation focuses...

Send us Fan Mail Late last week, AASLD published new practice guidance on the clinical assessment and management of NAFLD. The Surfers convene with Ken Cusi, who contributed to the previous iteration published in 2018, to explore its key features and implications. The updated document reflects the many advances pertinent to any practitioner caring for patients with NAFLD. This conversation introdu...

Send us Fan Mail Late last week, AASLD published new practice guidance on the clinical assessment and management of NAFLD. The Surfers convene with Ken Cusi, who contributed to the previous iteration published in 2018, to explore its key features and implications. The updated document reflects the many advances pertinent to any practitioner caring for patients with NAFLD. This conversation introdu...

Send us Fan Mail Late last week, AASLD published new practice guidance on the clinical assessment and management of NAFLD . To explore its key features and implications, the surfers convene with Ken Cusi, who contributed to the previous iteration published in 2018. The updated document reflects the many advances pertinent to any practitioner caring for patients with NAFLD. Notably, and as detailed...

Send us Fan Mail The entire Fatty Liver community benefits from NASH Patient Advocacy and the work of our advocates, but relatively few of us understand what advocates do or how we benefit from their work. Leading German patient advocate Achim Kautz and Global Liver Institute Vice President of Policy and Public Affairs Andrew Scott discuss how they came to Fatty Liver patient advocacy, their prior...

Send us Fan Mail In an introduction to Fatty Liver in Australia, Louise Campbell is joined by Tony Rahman, Director of Gastroenterology & Hepatology at The Prince Charles Hospital in Brisbane and Adjunct Professor in the College of Medicine and Dentistry at James Cook University. Louise leads this final conversation by highlighting the prospect of imminent drug approvals in the Fatty Liver spa...

Send us Fan Mail In an introduction to Fatty Liver in Australia, Louise Campbell is joined by Tony Rahman, Director of Gastroenterology & Hepatology at The Prince Charles Hospital in Brisbane and Adjunct Professor in the College of Medicine and Dentistry at James Cook University. Louise starts this conversation with an anecdote from her experiences in Australia providing virtual clinics to tho...

Send us Fan Mail In an introduction to Fatty Liver in Australia, Louise Campbell is joined by Tony Rahman, Director of Gastroenterology & Hepatology at The Prince Charles Hospital in Brisbane and Adjunct Professor in the College of Medicine and Dentistry at James Cook University. This conversation starts with Louise asking about the prevalence and composition of Australia’s Fatty Liver populat...

Send us Fan Mail In an introduction to Fatty Liver in Australia, Louise Campbell is joined by Tony Rahman, Director of Gastroenterology & Hepatology at The Prince Charles Hospital in Brisbane and Adjunct Professor in the College of Medicine and Dentistry at James Cook University. This opening conversation starts by following the path that took Tony from his training in London and his Doctor of...

Send us Fan Mail This week on the podcast, Louise Campbell leads the Surf in a one-on-one interview with Tony Rahman on what’s happening for Fatty Liver in Australia. Tony is the Director of Gastroenterology & Hepatology at The Prince Charles Hospital in Brisbane and Adjunct Professor in the College of Medicine and Dentistry at James Cook University. The episode begins with an introduction to...

Send us Fan Mail One of the most important challenges facing Fatty Liver stakeholders involves improving early diagnosis for patients with clinically relevant or advanced fibrosis (F2/3). Today, a significant percentage of patients learn they are living with cirrhosis in the Emergency Department during a decompensating event. Four in ten of these patients in the UK do not leave the hospital. In th...

Send us Fan Mail Surfing NASH is joined by Tim Jobson, Co-founder of Predictive Health Intelligence, to discuss a system by which historic blood test results are combined and analyzed to flag patients in need of intervention. This wrap-up conversation revisits many of the same themes explored in the preceding sessions: data aggregation, data transparency and patient enthusiasm to name a few. An im...

Send us Fan Mail Surfing NASH is joined by Tim Jobson, Co-founder of Predictive Health Intelligence , to discuss a system by which historic blood test results are combined and analyzed to flag patients in need of intervention. This conversation begins with focus on the dual issues of patient data and proactivity. Roger Green states that “the careful and intelligent use of early data to empower pat...

Send us Fan Mail Surfing NASH is joined by Tim Jobson, Co-founder of Predictive Health Intelligence , to discuss a system by which historic blood test results are combined and analyzed to flag patients in need of intervention. This conversation starts with a dialog between Tim and Roger Green around how simple the data and computations in this system appear to be. Roger describes a benefit in term...

Send us Fan Mail Surfing NASH is joined by Tim Jobson, Co-founder of Predictive Health Intelligence , to discuss a system by which historic blood test results are combined and analyzed to flag patients in need of intervention. This conversation starts with Jörn Schattenberg asking questions around the underlying system and whether the algorithm is “plastic?” This is based on the set of conditions...

Send us Fan Mail Surfing NASH is joined by Tim Jobson to discuss what he describes as a “combined informatics and clinical program simultaneously.” In this conversation, Tim begins by describing his background and how he came to partner with expert clinicians and specialists in healthcare IT to address how we can better identify liver patients in need of intervention. In partnership with former co...

Send us Fan Mail Surfing NASH is joined by Tim Jobson, founder of Predictive Health Intelligence , to discuss applying analytics to sieve through and distill invaluable data otherwise dormant in the NHS record systems. Tim, a Consultant Gastroenterologist and Fellow of the Royal College of Physicians, has firsthand experience with the shortcomings and frustrations around undiagnosed liver disease....

Send us Fan Mail As the podcast hosts insights from our very own audience this week, we are extending three additional conversations from recent reviews of a particularly exciting NASH-TAG 2023. This session features dialogue from a one-on-one interview with Donna Cryer, hosted by Roger Green. The episode begins with Roger mentioning what he found to be one of the most striking statistics from the...